

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.59260225 |
| 2 | behavioral response to nicotine (GO:0035095) | 5.54149394 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.51662749 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.28819352 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.20724773 |
| 6 | layer formation in cerebral cortex (GO:0021819) | 5.01329549 |
| 7 | vocalization behavior (GO:0071625) | 4.67948490 |
| 8 | glutamate secretion (GO:0014047) | 4.65635327 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.59998272 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.54114317 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.52237233 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.49735678 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.45335403 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.24899427 |
| 15 | exploration behavior (GO:0035640) | 4.22935683 |
| 16 | proline transport (GO:0015824) | 4.11671021 |
| 17 | dendritic spine morphogenesis (GO:0060997) | 4.07851088 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 4.04130833 |
| 19 | protein localization to synapse (GO:0035418) | 4.03892761 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 3.97361961 |
| 21 | dendrite morphogenesis (GO:0048813) | 3.94253276 |
| 22 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.93343809 |
| 23 | neurotransmitter secretion (GO:0007269) | 3.91721604 |
| 24 | regulation of synaptic vesicle transport (GO:1902803) | 3.90743097 |
| 25 | cell migration in hindbrain (GO:0021535) | 3.84353619 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.74709481 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.65960051 |
| 28 | activation of protein kinase A activity (GO:0034199) | 3.63525713 |
| 29 | presynaptic membrane assembly (GO:0097105) | 3.52290427 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.51837781 |
| 31 | neuron recognition (GO:0008038) | 3.51721475 |
| 32 | positive regulation of synapse maturation (GO:0090129) | 3.51547436 |
| 33 | axonal fasciculation (GO:0007413) | 3.50847117 |
| 34 | presynaptic membrane organization (GO:0097090) | 3.47878962 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 3.41627849 |
| 36 | nucleobase catabolic process (GO:0046113) | 3.36665296 |
| 37 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.35081674 |
| 38 | sodium ion export (GO:0071436) | 3.32435251 |
| 39 | cell communication by electrical coupling (GO:0010644) | 3.31187537 |
| 40 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.30215674 |
| 41 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.27527323 |
| 42 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.27527323 |
| 43 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.27527323 |
| 44 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.27122101 |
| 45 | startle response (GO:0001964) | 3.24764255 |
| 46 | L-fucose catabolic process (GO:0042355) | 3.24726797 |
| 47 | fucose catabolic process (GO:0019317) | 3.24726797 |
| 48 | L-fucose metabolic process (GO:0042354) | 3.24726797 |
| 49 | transmission of nerve impulse (GO:0019226) | 3.22644915 |
| 50 | cellular potassium ion homeostasis (GO:0030007) | 3.19871323 |
| 51 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.19293326 |
| 52 | neuromuscular process controlling balance (GO:0050885) | 3.19118018 |
| 53 | regulation of ARF protein signal transduction (GO:0032012) | 3.17587089 |
| 54 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.16387717 |
| 55 | mechanosensory behavior (GO:0007638) | 3.13264937 |
| 56 | neuronal action potential propagation (GO:0019227) | 3.11697489 |
| 57 | cerebellar Purkinje cell layer development (GO:0021680) | 3.08413117 |
| 58 | synaptic transmission, glutamatergic (GO:0035249) | 3.07281353 |
| 59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.06691860 |
| 60 | neuronal action potential (GO:0019228) | 3.05301920 |
| 61 | tryptophan catabolic process (GO:0006569) | 3.05105387 |
| 62 | indole-containing compound catabolic process (GO:0042436) | 3.05105387 |
| 63 | indolalkylamine catabolic process (GO:0046218) | 3.05105387 |
| 64 | limb bud formation (GO:0060174) | 3.05001891 |
| 65 | kynurenine metabolic process (GO:0070189) | 3.01790746 |
| 66 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.00775705 |
| 67 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.00483825 |
| 68 | glutamate receptor signaling pathway (GO:0007215) | 3.00192876 |
| 69 | innervation (GO:0060384) | 2.99209583 |
| 70 | response to pheromone (GO:0019236) | 2.98594081 |
| 71 | neurotransmitter transport (GO:0006836) | 2.97634339 |
| 72 | retinal ganglion cell axon guidance (GO:0031290) | 2.97106102 |
| 73 | auditory behavior (GO:0031223) | 2.96115381 |
| 74 | regulation of action potential (GO:0098900) | 2.96078485 |
| 75 | synaptic transmission, cholinergic (GO:0007271) | 2.95437655 |
| 76 | long-term memory (GO:0007616) | 2.94738427 |
| 77 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.93773183 |
| 78 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.93759914 |
| 79 | vesicle transport along microtubule (GO:0047496) | 2.93624424 |
| 80 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.92673645 |
| 81 | neuromuscular synaptic transmission (GO:0007274) | 2.92473626 |
| 82 | organelle transport along microtubule (GO:0072384) | 2.92470024 |
| 83 | positive regulation of membrane potential (GO:0045838) | 2.91354783 |
| 84 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.90955712 |
| 85 | axon extension (GO:0048675) | 2.90206503 |
| 86 | clathrin coat assembly (GO:0048268) | 2.90120616 |
| 87 | protein polyglutamylation (GO:0018095) | 2.88924544 |
| 88 | postsynaptic membrane organization (GO:0001941) | 2.88691483 |
| 89 | synaptic vesicle endocytosis (GO:0048488) | 2.87909732 |
| 90 | regulation of respiratory system process (GO:0044065) | 2.87503738 |
| 91 | establishment of nucleus localization (GO:0040023) | 2.87363379 |
| 92 | establishment of mitochondrion localization (GO:0051654) | 2.86818366 |
| 93 | regulation of synaptic plasticity (GO:0048167) | 2.86814686 |
| 94 | regulation of neurotransmitter secretion (GO:0046928) | 2.84732572 |
| 95 | spinal cord development (GO:0021510) | 2.84239146 |
| 96 | neuron-neuron synaptic transmission (GO:0007270) | 2.83626096 |
| 97 | membrane depolarization during action potential (GO:0086010) | 2.83527663 |
| 98 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.82725575 |
| 99 | nonmotile primary cilium assembly (GO:0035058) | 2.82410053 |
| 100 | regulation of postsynaptic membrane potential (GO:0060078) | 2.81660337 |
| 101 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.81575160 |
| 102 | alanine transport (GO:0032328) | 2.81305037 |
| 103 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.80969494 |
| 104 | cell communication involved in cardiac conduction (GO:0086065) | 2.80029429 |
| 105 | regulation of neurotransmitter levels (GO:0001505) | 2.80020461 |
| 106 | response to auditory stimulus (GO:0010996) | 2.79818920 |
| 107 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.79519763 |
| 108 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.79337123 |
| 109 | dendritic spine organization (GO:0097061) | 2.78326303 |
| 110 | negative regulation of microtubule polymerization (GO:0031115) | 2.78141908 |
| 111 | atrial cardiac muscle cell action potential (GO:0086014) | 2.77852103 |
| 112 | axon cargo transport (GO:0008088) | 2.77433881 |
| 113 | glycine transport (GO:0015816) | 2.77303125 |
| 114 | central nervous system neuron axonogenesis (GO:0021955) | 2.76308351 |
| 115 | positive regulation of fibroblast migration (GO:0010763) | 2.76224670 |
| 116 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.71969664 |
| 117 | behavioral response to ethanol (GO:0048149) | 2.71742949 |
| 118 | cornea development in camera-type eye (GO:0061303) | 2.70789038 |
| 119 | prepulse inhibition (GO:0060134) | 2.70321764 |
| 120 | synapse assembly (GO:0007416) | 2.70131195 |
| 121 | neuron maturation (GO:0042551) | 2.69304266 |
| 122 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.68678800 |
| 123 | positive regulation of axon extension (GO:0045773) | 2.67965432 |
| 124 | social behavior (GO:0035176) | 2.67774690 |
| 125 | intraspecies interaction between organisms (GO:0051703) | 2.67774690 |
| 126 | synapse organization (GO:0050808) | 2.66742999 |
| 127 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.64247368 |
| 128 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.63476699 |
| 129 | neuromuscular process (GO:0050905) | 2.62163744 |
| 130 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.61527784 |
| 131 | positive regulation of synapse assembly (GO:0051965) | 2.61392644 |
| 132 | mitochondrion transport along microtubule (GO:0047497) | 2.61045838 |
| 133 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.61045838 |
| 134 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.60911040 |
| 135 | negative regulation of mast cell activation (GO:0033004) | 2.60114306 |
| 136 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.59471017 |
| 137 | neuron projection extension (GO:1990138) | 2.59335226 |
| 138 | cerebellum development (GO:0021549) | 2.59066100 |
| 139 | cellular sodium ion homeostasis (GO:0006883) | 2.58394351 |
| 140 | indolalkylamine metabolic process (GO:0006586) | 2.57909227 |
| 141 | neural tube formation (GO:0001841) | 2.57354895 |
| 142 | action potential (GO:0001508) | 2.55915210 |
| 143 | regulation of axon guidance (GO:1902667) | 2.55557313 |
| 144 | adult walking behavior (GO:0007628) | 2.55544420 |
| 145 | protein localization to cilium (GO:0061512) | 2.54623969 |
| 146 | regulation of respiratory gaseous exchange (GO:0043576) | 2.52714012 |
| 147 | sympathetic nervous system development (GO:0048485) | 2.51108602 |
| 148 | negative regulation of axon guidance (GO:1902668) | 2.51046174 |
| 149 | regulation of hippo signaling (GO:0035330) | 2.48787561 |
| 150 | regulation of telomere maintenance (GO:0032204) | 2.48650851 |
| 151 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.46671809 |
| 152 | detection of light stimulus involved in visual perception (GO:0050908) | 2.46671809 |
| 153 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.46077642 |
| 154 | neurofilament cytoskeleton organization (GO:0060052) | 2.44890628 |
| 155 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.44213843 |
| 156 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.43903016 |
| 157 | reflex (GO:0060004) | 2.43593445 |
| 158 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.43500964 |
| 159 | serotonin metabolic process (GO:0042428) | 2.42859776 |
| 160 | glycerophospholipid catabolic process (GO:0046475) | 2.41457326 |
| 161 | glycosphingolipid biosynthetic process (GO:0006688) | 2.41117102 |
| 162 | regulation of membrane repolarization (GO:0060306) | 2.40595648 |
| 163 | primary amino compound metabolic process (GO:1901160) | 2.40301261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.28441071 |
| 2 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.74606508 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.74173119 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.70552600 |
| 5 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.58030235 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.58030235 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.51450536 |
| 8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.49592574 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.49199130 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.42563587 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.38467240 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.37558928 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35702343 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35540862 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.32959818 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.31111578 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.26260131 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.24065377 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.23249651 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16803743 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 2.15022383 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13636944 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12816868 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.11970911 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.01969558 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.01742840 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.01529387 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01198433 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.96791039 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.96284904 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.93659094 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.91642142 |
| 33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.89156210 |
| 34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.85978720 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76173257 |
| 36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74934275 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.65296613 |
| 38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.64060922 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.62973655 |
| 40 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.61570758 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.59662301 |
| 42 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57903667 |
| 43 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.57903667 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55892561 |
| 45 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.53933043 |
| 46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.52840870 |
| 47 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.49426329 |
| 48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49008272 |
| 49 | EWS_26573619_Chip-Seq_HEK293_Human | 1.47145233 |
| 50 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.44391907 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42142424 |
| 52 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.42069635 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41790705 |
| 54 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.40056648 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.38060088 |
| 56 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.36825214 |
| 57 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36570937 |
| 58 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33675901 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33411842 |
| 60 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32344796 |
| 61 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.32095849 |
| 62 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30942001 |
| 63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.30650612 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30465487 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29985906 |
| 66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29662402 |
| 67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.29511211 |
| 68 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28900763 |
| 69 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.27856425 |
| 70 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.26445475 |
| 71 | AR_19668381_ChIP-Seq_PC3_Human | 1.25437669 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25415948 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.24062408 |
| 74 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22836447 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21985584 |
| 76 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.21788801 |
| 77 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.21683746 |
| 78 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.21683746 |
| 79 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21149588 |
| 80 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20783094 |
| 81 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.20687208 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18193443 |
| 83 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17415037 |
| 84 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16889975 |
| 85 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16729987 |
| 86 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.16480868 |
| 87 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16311381 |
| 88 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.13676690 |
| 89 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.13067769 |
| 90 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12823070 |
| 91 | TP53_16413492_ChIP-PET_HCT116_Human | 1.11318330 |
| 92 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10266470 |
| 93 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07925534 |
| 94 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07712294 |
| 95 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07582367 |
| 96 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06895135 |
| 97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06322898 |
| 98 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06268577 |
| 99 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05870632 |
| 100 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04612207 |
| 101 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.04538381 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04092505 |
| 103 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.03669779 |
| 104 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.03459391 |
| 105 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02800298 |
| 106 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01953752 |
| 107 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.01924409 |
| 108 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.01411726 |
| 109 | STAT3_23295773_ChIP-Seq_U87_Human | 1.01143910 |
| 110 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.00576342 |
| 111 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00355693 |
| 112 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.00123910 |
| 113 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99788197 |
| 114 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.99215597 |
| 115 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98044314 |
| 116 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.97964444 |
| 117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97291311 |
| 118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97013254 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96984071 |
| 120 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96893240 |
| 121 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96558216 |
| 122 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95896304 |
| 123 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94152982 |
| 124 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94122023 |
| 125 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93946472 |
| 126 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.93283755 |
| 127 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.92511231 |
| 128 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92453700 |
| 129 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92280721 |
| 130 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92119708 |
| 131 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.91599392 |
| 132 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.91346382 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.91034620 |
| 134 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.90699337 |
| 135 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90309358 |
| 136 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89989304 |
| 137 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89505891 |
| 138 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89487586 |
| 139 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88792207 |
| 140 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87931288 |
| 141 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.86652021 |
| 142 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.85417318 |
| 143 | P300_19829295_ChIP-Seq_ESCs_Human | 0.84949624 |
| 144 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84640222 |
| 145 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84619473 |
| 146 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.83622047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.30557724 |
| 2 | MP0004270_analgesia | 4.00515475 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.80507546 |
| 4 | MP0003880_abnormal_central_pattern | 3.77066821 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.02510209 |
| 6 | MP0005423_abnormal_somatic_nervous | 2.94497434 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 2.90820863 |
| 8 | MP0009745_abnormal_behavioral_response | 2.69652201 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 2.66044673 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.64210723 |
| 11 | MP0002064_seizures | 2.50913553 |
| 12 | MP0004858_abnormal_nervous_system | 2.41930716 |
| 13 | MP0009046_muscle_twitch | 2.36403213 |
| 14 | MP0002909_abnormal_adrenal_gland | 2.35498602 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.31853975 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.31019173 |
| 17 | MP0000778_abnormal_nervous_system | 2.29473124 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.21085776 |
| 19 | MP0002733_abnormal_thermal_nociception | 2.18122388 |
| 20 | MP0002184_abnormal_innervation | 2.06459652 |
| 21 | MP0001486_abnormal_startle_reflex | 2.04697300 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.01465184 |
| 23 | MP0004811_abnormal_neuron_physiology | 2.00018116 |
| 24 | MP0004142_abnormal_muscle_tone | 1.90577427 |
| 25 | MP0004133_heterotaxia | 1.89708768 |
| 26 | MP0008877_abnormal_DNA_methylation | 1.87537375 |
| 27 | MP0002272_abnormal_nervous_system | 1.87204028 |
| 28 | MP0003329_amyloid_beta_deposits | 1.87139426 |
| 29 | MP0001970_abnormal_pain_threshold | 1.85779162 |
| 30 | MP0002822_catalepsy | 1.83264529 |
| 31 | MP0002736_abnormal_nociception_after | 1.78236158 |
| 32 | MP0001440_abnormal_grooming_behavior | 1.75186714 |
| 33 | MP0005551_abnormal_eye_electrophysiolog | 1.74373891 |
| 34 | MP0002653_abnormal_ependyma_morphology | 1.73613161 |
| 35 | MP0000955_abnormal_spinal_cord | 1.73123548 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.71479852 |
| 37 | MP0001529_abnormal_vocalization | 1.70330061 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.66325299 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.64433803 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.62939018 |
| 41 | MP0002067_abnormal_sensory_capabilities | 1.62475816 |
| 42 | MP0003195_calcinosis | 1.58805469 |
| 43 | MP0008569_lethality_at_weaning | 1.58804890 |
| 44 | MP0002102_abnormal_ear_morphology | 1.57251116 |
| 45 | MP0004924_abnormal_behavior | 1.55698831 |
| 46 | MP0005386_behavior/neurological_phenoty | 1.55698831 |
| 47 | MP0004742_abnormal_vestibular_system | 1.53095678 |
| 48 | MP0008961_abnormal_basal_metabolism | 1.50741007 |
| 49 | MP0004043_abnormal_pH_regulation | 1.48575337 |
| 50 | MP0004885_abnormal_endolymph | 1.46712949 |
| 51 | MP0003646_muscle_fatigue | 1.45054940 |
| 52 | MP0001984_abnormal_olfaction | 1.44361250 |
| 53 | MP0003890_abnormal_embryonic-extraembry | 1.44161162 |
| 54 | MP0003879_abnormal_hair_cell | 1.43572366 |
| 55 | MP0002882_abnormal_neuron_morphology | 1.41691245 |
| 56 | MP0001188_hyperpigmentation | 1.38032802 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.37977141 |
| 58 | MP0001485_abnormal_pinna_reflex | 1.37207630 |
| 59 | MP0003121_genomic_imprinting | 1.35817554 |
| 60 | MP0003122_maternal_imprinting | 1.34515876 |
| 61 | MP0002751_abnormal_autonomic_nervous | 1.29495501 |
| 62 | MP0005646_abnormal_pituitary_gland | 1.29057423 |
| 63 | MP0002066_abnormal_motor_capabilities/c | 1.28175586 |
| 64 | MP0010234_abnormal_vibrissa_follicle | 1.27688061 |
| 65 | MP0003136_yellow_coat_color | 1.27440944 |
| 66 | MP0002876_abnormal_thyroid_physiology | 1.26927317 |
| 67 | MP0003283_abnormal_digestive_organ | 1.24318878 |
| 68 | MP0005187_abnormal_penis_morphology | 1.23962987 |
| 69 | MP0000751_myopathy | 1.23595941 |
| 70 | MP0002152_abnormal_brain_morphology | 1.19037890 |
| 71 | MP0000013_abnormal_adipose_tissue | 1.15749246 |
| 72 | MP0003633_abnormal_nervous_system | 1.11898629 |
| 73 | MP0005253_abnormal_eye_physiology | 1.11247646 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.11217456 |
| 75 | MP0000427_abnormal_hair_cycle | 1.11114477 |
| 76 | MP0005174_abnormal_tail_pigmentation | 1.08833046 |
| 77 | MP0008872_abnormal_physiological_respon | 1.06316636 |
| 78 | MP0001299_abnormal_eye_distance/ | 1.06295355 |
| 79 | MP0004130_abnormal_muscle_cell | 1.06085651 |
| 80 | MP0006292_abnormal_olfactory_placode | 1.05654242 |
| 81 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03120935 |
| 82 | MP0006072_abnormal_retinal_apoptosis | 1.01657960 |
| 83 | MP0001502_abnormal_circadian_rhythm | 1.00968913 |
| 84 | MP0001348_abnormal_lacrimal_gland | 0.99679494 |
| 85 | MP0002234_abnormal_pharynx_morphology | 0.98596802 |
| 86 | MP0005195_abnormal_posterior_eye | 0.97657848 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 0.97313709 |
| 88 | MP0002938_white_spotting | 0.96371904 |
| 89 | MP0005499_abnormal_olfactory_system | 0.95086547 |
| 90 | MP0005394_taste/olfaction_phenotype | 0.95086547 |
| 91 | MP0010386_abnormal_urinary_bladder | 0.94852843 |
| 92 | MP0003787_abnormal_imprinting | 0.92811600 |
| 93 | MP0004085_abnormal_heartbeat | 0.91875440 |
| 94 | MP0005623_abnormal_meninges_morphology | 0.90984782 |
| 95 | MP0002928_abnormal_bile_duct | 0.89725937 |
| 96 | MP0000026_abnormal_inner_ear | 0.88239507 |
| 97 | MP0003631_nervous_system_phenotype | 0.87725973 |
| 98 | MP0000537_abnormal_urethra_morphology | 0.87587626 |
| 99 | MP0004233_abnormal_muscle_weight | 0.85774673 |
| 100 | MP0003634_abnormal_glial_cell | 0.85399496 |
| 101 | MP0000604_amyloidosis | 0.83826584 |
| 102 | MP0001177_atelectasis | 0.82197191 |
| 103 | MP0004145_abnormal_muscle_electrophysio | 0.82023709 |
| 104 | MP0003011_delayed_dark_adaptation | 0.81807584 |
| 105 | MP0003861_abnormal_nervous_system | 0.81588536 |
| 106 | MP0008995_early_reproductive_senescence | 0.81448173 |
| 107 | MP0001963_abnormal_hearing_physiology | 0.81178914 |
| 108 | MP0000647_abnormal_sebaceous_gland | 0.78173057 |
| 109 | MP0003172_abnormal_lysosome_physiology | 0.76546742 |
| 110 | MP0005535_abnormal_body_temperature | 0.76040274 |
| 111 | MP0000631_abnormal_neuroendocrine_gland | 0.75865645 |
| 112 | MP0003137_abnormal_impulse_conducting | 0.74841504 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.73465851 |
| 114 | MP0005448_abnormal_energy_balance | 0.72330480 |
| 115 | MP0003937_abnormal_limbs/digits/tail_de | 0.72228649 |
| 116 | MP0000383_abnormal_hair_follicle | 0.72185793 |
| 117 | MP0008874_decreased_physiological_sensi | 0.71675265 |
| 118 | MP0000534_abnormal_ureter_morphology | 0.67068145 |
| 119 | MP0002229_neurodegeneration | 0.66697446 |
| 120 | MP0004215_abnormal_myocardial_fiber | 0.64711054 |
| 121 | MP0004484_altered_response_of | 0.64465115 |
| 122 | MP0002752_abnormal_somatic_nervous | 0.63346167 |
| 123 | MP0004510_myositis | 0.63163017 |
| 124 | MP0002089_abnormal_postnatal_growth/wei | 0.62096545 |
| 125 | MP0000747_muscle_weakness | 0.61296531 |
| 126 | MP0003303_peritoneal_inflammation | 0.61274568 |
| 127 | MP0010769_abnormal_survival | 0.58808285 |
| 128 | MP0003183_abnormal_peptide_metabolism | 0.58187019 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.57749192 |
| 130 | MP0002082_postnatal_lethality | 0.57080023 |
| 131 | MP0010770_preweaning_lethality | 0.57080023 |
| 132 | MP0002896_abnormal_bone_mineralization | 0.56322559 |
| 133 | MP0001943_abnormal_respiration | 0.55988038 |
| 134 | MP0001905_abnormal_dopamine_level | 0.55904488 |
| 135 | MP0003632_abnormal_nervous_system | 0.55700094 |
| 136 | MP0003119_abnormal_digestive_system | 0.54021346 |
| 137 | MP0002090_abnormal_vision | 0.53606762 |
| 138 | MP0010768_mortality/aging | 0.53047436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 5.20767227 |
| 2 | Focal motor seizures (HP:0011153) | 4.62503307 |
| 3 | Focal seizures (HP:0007359) | 4.44768883 |
| 4 | Visual hallucinations (HP:0002367) | 4.26991235 |
| 5 | Supranuclear gaze palsy (HP:0000605) | 3.92779359 |
| 6 | Pancreatic cysts (HP:0001737) | 3.71919461 |
| 7 | Abnormality of midbrain morphology (HP:0002418) | 3.55063338 |
| 8 | Molar tooth sign on MRI (HP:0002419) | 3.55063338 |
| 9 | Action tremor (HP:0002345) | 3.49489300 |
| 10 | Ankle clonus (HP:0011448) | 3.34048805 |
| 11 | Nephronophthisis (HP:0000090) | 3.31596056 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.29655898 |
| 13 | Epileptic encephalopathy (HP:0200134) | 3.23641722 |
| 14 | Protruding tongue (HP:0010808) | 3.22106454 |
| 15 | Inability to walk (HP:0002540) | 3.20841346 |
| 16 | Type II lissencephaly (HP:0007260) | 3.17808692 |
| 17 | Papilledema (HP:0001085) | 3.14068677 |
| 18 | Lissencephaly (HP:0001339) | 3.13142688 |
| 19 | Mutism (HP:0002300) | 3.11076393 |
| 20 | True hermaphroditism (HP:0010459) | 3.07371795 |
| 21 | Atonic seizures (HP:0010819) | 3.02001093 |
| 22 | Congenital stationary night blindness (HP:0007642) | 3.01463247 |
| 23 | Poor eye contact (HP:0000817) | 2.94488980 |
| 24 | Pancreatic fibrosis (HP:0100732) | 2.93733631 |
| 25 | Genetic anticipation (HP:0003743) | 2.90888910 |
| 26 | Absence seizures (HP:0002121) | 2.85918248 |
| 27 | Abnormal social behavior (HP:0012433) | 2.85514672 |
| 28 | Impaired social interactions (HP:0000735) | 2.85514672 |
| 29 | Chronic hepatic failure (HP:0100626) | 2.82382364 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.82278372 |
| 31 | Abnormality of the renal medulla (HP:0100957) | 2.80520151 |
| 32 | Generalized tonic-clonic seizures (HP:0002069) | 2.78998406 |
| 33 | Depression (HP:0000716) | 2.78854745 |
| 34 | Termporal pattern (HP:0011008) | 2.77337185 |
| 35 | Insidious onset (HP:0003587) | 2.77337185 |
| 36 | Febrile seizures (HP:0002373) | 2.76511963 |
| 37 | Megalencephaly (HP:0001355) | 2.75998063 |
| 38 | Drooling (HP:0002307) | 2.73289622 |
| 39 | Excessive salivation (HP:0003781) | 2.73289622 |
| 40 | Medial flaring of the eyebrow (HP:0010747) | 2.68906423 |
| 41 | Insomnia (HP:0100785) | 2.67048820 |
| 42 | Gait imbalance (HP:0002141) | 2.66299299 |
| 43 | Abnormality of the lower motor neuron (HP:0002366) | 2.61795432 |
| 44 | Torticollis (HP:0000473) | 2.60936835 |
| 45 | Elfin facies (HP:0004428) | 2.60936245 |
| 46 | Urinary urgency (HP:0000012) | 2.57070440 |
| 47 | Dialeptic seizures (HP:0011146) | 2.55770015 |
| 48 | Truncal ataxia (HP:0002078) | 2.54990498 |
| 49 | Ventricular fibrillation (HP:0001663) | 2.54707683 |
| 50 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.53861658 |
| 51 | Tubular atrophy (HP:0000092) | 2.53721782 |
| 52 | Abnormal eating behavior (HP:0100738) | 2.52614153 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 2.51009919 |
| 54 | Broad-based gait (HP:0002136) | 2.49864185 |
| 55 | Agitation (HP:0000713) | 2.47789285 |
| 56 | Hyperacusis (HP:0010780) | 2.46368001 |
| 57 | Postural instability (HP:0002172) | 2.45775290 |
| 58 | Absent speech (HP:0001344) | 2.44350349 |
| 59 | Abnormality of the labia minora (HP:0012880) | 2.44331988 |
| 60 | Bundle branch block (HP:0011710) | 2.42119785 |
| 61 | Limb dystonia (HP:0002451) | 2.36503840 |
| 62 | Amblyopia (HP:0000646) | 2.36435999 |
| 63 | Focal dystonia (HP:0004373) | 2.32500561 |
| 64 | Abnormality of the renal cortex (HP:0011035) | 2.31030181 |
| 65 | EEG with generalized epileptiform discharges (HP:0011198) | 2.30999719 |
| 66 | Dysdiadochokinesis (HP:0002075) | 2.30920169 |
| 67 | Macroorchidism (HP:0000053) | 2.30418179 |
| 68 | Hypsarrhythmia (HP:0002521) | 2.28282713 |
| 69 | Epileptiform EEG discharges (HP:0011182) | 2.27574832 |
| 70 | Amyotrophic lateral sclerosis (HP:0007354) | 2.26569078 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.25008710 |
| 72 | Anxiety (HP:0000739) | 2.24626826 |
| 73 | Abnormality of the corticospinal tract (HP:0002492) | 2.24014520 |
| 74 | Large for gestational age (HP:0001520) | 2.23203256 |
| 75 | Cerebellar dysplasia (HP:0007033) | 2.20296801 |
| 76 | Stereotypic behavior (HP:0000733) | 2.18268043 |
| 77 | Cystic liver disease (HP:0006706) | 2.17920919 |
| 78 | Pointed chin (HP:0000307) | 2.17473718 |
| 79 | Prolonged QT interval (HP:0001657) | 2.17358311 |
| 80 | Congenital primary aphakia (HP:0007707) | 2.16876774 |
| 81 | Akinesia (HP:0002304) | 2.16858367 |
| 82 | Pheochromocytoma (HP:0002666) | 2.16009401 |
| 83 | Attenuation of retinal blood vessels (HP:0007843) | 2.15353452 |
| 84 | Impaired smooth pursuit (HP:0007772) | 2.15339957 |
| 85 | Spastic gait (HP:0002064) | 2.14343882 |
| 86 | Hemiplegia (HP:0002301) | 2.14157835 |
| 87 | Patellar aplasia (HP:0006443) | 2.13602403 |
| 88 | Polyphagia (HP:0002591) | 2.12257380 |
| 89 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.12102622 |
| 90 | Abnormality of alanine metabolism (HP:0010916) | 2.12102622 |
| 91 | Hyperalaninemia (HP:0003348) | 2.12102622 |
| 92 | Craniofacial dystonia (HP:0012179) | 2.11153144 |
| 93 | Failure to thrive in infancy (HP:0001531) | 2.10668960 |
| 94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.10128556 |
| 95 | Dysmetric saccades (HP:0000641) | 2.10065373 |
| 96 | Dysmetria (HP:0001310) | 2.08950867 |
| 97 | Obstructive sleep apnea (HP:0002870) | 2.08390861 |
| 98 | Hemiparesis (HP:0001269) | 2.08280076 |
| 99 | Fetal akinesia sequence (HP:0001989) | 2.07449643 |
| 100 | Lower limb muscle weakness (HP:0007340) | 2.07317750 |
| 101 | Sclerocornea (HP:0000647) | 2.06821706 |
| 102 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.05574935 |
| 103 | Nephrogenic diabetes insipidus (HP:0009806) | 2.05558686 |
| 104 | Genital tract atresia (HP:0001827) | 2.04149001 |
| 105 | Lower limb amyotrophy (HP:0007210) | 2.03916658 |
| 106 | Vaginal atresia (HP:0000148) | 2.03211391 |
| 107 | Chorioretinal atrophy (HP:0000533) | 2.01457530 |
| 108 | Abnormal drinking behavior (HP:0030082) | 2.00835011 |
| 109 | Polydipsia (HP:0001959) | 2.00835011 |
| 110 | Apathy (HP:0000741) | 2.00415328 |
| 111 | Bradykinesia (HP:0002067) | 1.99464540 |
| 112 | Progressive inability to walk (HP:0002505) | 1.98174657 |
| 113 | Clumsiness (HP:0002312) | 1.97733896 |
| 114 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.97079460 |
| 115 | Hypoplasia of the brainstem (HP:0002365) | 1.97079460 |
| 116 | Pendular nystagmus (HP:0012043) | 1.96700832 |
| 117 | Inappropriate behavior (HP:0000719) | 1.95642880 |
| 118 | Hepatoblastoma (HP:0002884) | 1.95619229 |
| 119 | Neoplasm of the heart (HP:0100544) | 1.95043934 |
| 120 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.94840302 |
| 121 | Anencephaly (HP:0002323) | 1.93640182 |
| 122 | Hyperventilation (HP:0002883) | 1.93546225 |
| 123 | Concave nail (HP:0001598) | 1.93421921 |
| 124 | Gaze-evoked nystagmus (HP:0000640) | 1.93127085 |
| 125 | Retinal dysplasia (HP:0007973) | 1.92120415 |
| 126 | Polymicrogyria (HP:0002126) | 1.91261039 |
| 127 | Aqueductal stenosis (HP:0002410) | 1.89717177 |
| 128 | Partial agenesis of the corpus callosum (HP:0001338) | 1.87003486 |
| 129 | Macroglossia (HP:0000158) | 1.86278381 |
| 130 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.84946161 |
| 131 | Severe muscular hypotonia (HP:0006829) | 1.84574096 |
| 132 | Hypoventilation (HP:0002791) | 1.84378673 |
| 133 | Open mouth (HP:0000194) | 1.83134603 |
| 134 | Overriding aorta (HP:0002623) | 1.83045564 |
| 135 | Abnormality of salivation (HP:0100755) | 1.82890560 |
| 136 | Abnormality of the pons (HP:0007361) | 1.82420051 |
| 137 | Intention tremor (HP:0002080) | 1.82113299 |
| 138 | Fair hair (HP:0002286) | 1.81626443 |
| 139 | Neuroendocrine neoplasm (HP:0100634) | 1.81149633 |
| 140 | Widely spaced teeth (HP:0000687) | 1.81026719 |
| 141 | Hypercortisolism (HP:0001578) | 1.80851466 |
| 142 | Renovascular hypertension (HP:0100817) | 1.80532516 |
| 143 | Exotropia (HP:0000577) | 1.79806737 |
| 144 | Status epilepticus (HP:0002133) | 1.79037609 |
| 145 | Diminished motivation (HP:0000745) | 1.78983802 |
| 146 | Narrow forehead (HP:0000341) | 1.78851394 |
| 147 | Hypoplasia of the pons (HP:0012110) | 1.78714966 |
| 148 | Sacral dimple (HP:0000960) | 1.78395761 |
| 149 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.77625693 |
| 150 | Poor coordination (HP:0002370) | 1.77489952 |
| 151 | Pachygyria (HP:0001302) | 1.76757687 |
| 152 | Rapidly progressive (HP:0003678) | 1.76699332 |
| 153 | Intellectual disability, profound (HP:0002187) | 1.76675713 |
| 154 | Ankyloglossia (HP:0010296) | 1.74529384 |
| 155 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.73956209 |
| 156 | Specific learning disability (HP:0001328) | 1.73906269 |
| 157 | Abolished electroretinogram (ERG) (HP:0000550) | 1.73107214 |
| 158 | Spastic tetraplegia (HP:0002510) | 1.72481496 |
| 159 | Oligodactyly (hands) (HP:0001180) | 1.71593835 |
| 160 | Polyuria (HP:0000103) | 1.71462786 |
| 161 | Keratoconus (HP:0000563) | 1.71436523 |
| 162 | Increased corneal curvature (HP:0100692) | 1.71436523 |
| 163 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.70750097 |
| 164 | Ulnar claw (HP:0001178) | 1.70547635 |
| 165 | Optic nerve hypoplasia (HP:0000609) | 1.64278161 |
| 166 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.64173007 |
| 167 | Congenital sensorineural hearing impairment (HP:0008527) | 1.63054889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.05510365 |
| 2 | MAP3K9 | 4.14566886 |
| 3 | NTRK3 | 3.57883327 |
| 4 | MINK1 | 2.62751111 |
| 5 | MAP3K4 | 2.58183322 |
| 6 | PINK1 | 2.52415809 |
| 7 | EPHA4 | 2.46727941 |
| 8 | DAPK2 | 2.45499722 |
| 9 | ADRBK2 | 2.42555129 |
| 10 | PAK6 | 2.35795482 |
| 11 | TNIK | 2.19658590 |
| 12 | BMPR1B | 2.13610283 |
| 13 | NTRK2 | 2.08959815 |
| 14 | KSR2 | 1.98272787 |
| 15 | LATS2 | 1.93139853 |
| 16 | PRKD3 | 1.90912280 |
| 17 | NTRK1 | 1.88967913 |
| 18 | CAMKK1 | 1.86588990 |
| 19 | PHKG2 | 1.83369609 |
| 20 | PHKG1 | 1.83369609 |
| 21 | TLK1 | 1.80640057 |
| 22 | SIK2 | 1.79442247 |
| 23 | MAP2K7 | 1.78191622 |
| 24 | MAP2K4 | 1.75291860 |
| 25 | MKNK2 | 1.73091711 |
| 26 | ACVR1B | 1.70632590 |
| 27 | KSR1 | 1.68700342 |
| 28 | TRIM28 | 1.65549538 |
| 29 | MAP3K2 | 1.47786731 |
| 30 | ZAK | 1.46844103 |
| 31 | CDK5 | 1.45175247 |
| 32 | TRIB3 | 1.43705767 |
| 33 | INSRR | 1.38323586 |
| 34 | RIPK1 | 1.37894770 |
| 35 | GRK1 | 1.34958766 |
| 36 | MAP4K2 | 1.34744753 |
| 37 | MAPK13 | 1.31720332 |
| 38 | WNK4 | 1.30356023 |
| 39 | RET | 1.30173142 |
| 40 | BCR | 1.26328689 |
| 41 | TAOK1 | 1.25564224 |
| 42 | STK38 | 1.24494538 |
| 43 | TYRO3 | 1.20015414 |
| 44 | LMTK2 | 1.20011522 |
| 45 | PAK3 | 1.13868765 |
| 46 | UHMK1 | 1.11410705 |
| 47 | CAMK1G | 1.10590923 |
| 48 | MARK2 | 1.05019388 |
| 49 | DAPK1 | 1.04935368 |
| 50 | SGK3 | 0.98523103 |
| 51 | MAP3K12 | 0.97501413 |
| 52 | SGK223 | 0.97245247 |
| 53 | SGK494 | 0.97245247 |
| 54 | SCYL2 | 0.97000668 |
| 55 | GRK5 | 0.96072628 |
| 56 | ALK | 0.95451899 |
| 57 | PRKCH | 0.94600395 |
| 58 | AKT3 | 0.94294994 |
| 59 | CSNK1G2 | 0.94096365 |
| 60 | EPHA3 | 0.94049861 |
| 61 | STK11 | 0.92700567 |
| 62 | SGK2 | 0.92444763 |
| 63 | PRKCG | 0.92179579 |
| 64 | OXSR1 | 0.91783416 |
| 65 | CSNK1G1 | 0.91503416 |
| 66 | MAPK15 | 0.86800252 |
| 67 | PKN1 | 0.84166688 |
| 68 | FGFR2 | 0.82436177 |
| 69 | ADRBK1 | 0.80427887 |
| 70 | PLK2 | 0.80207048 |
| 71 | PDGFRA | 0.79985769 |
| 72 | PRKCE | 0.79939807 |
| 73 | ICK | 0.78488210 |
| 74 | PKN2 | 0.78045182 |
| 75 | RPS6KA2 | 0.77978806 |
| 76 | STK39 | 0.76730231 |
| 77 | EPHB2 | 0.76594506 |
| 78 | MAP3K7 | 0.76024996 |
| 79 | PRKCZ | 0.75082979 |
| 80 | CDK14 | 0.73870344 |
| 81 | DYRK2 | 0.73808693 |
| 82 | CDK18 | 0.72966464 |
| 83 | ERBB3 | 0.72913503 |
| 84 | CDK15 | 0.72522101 |
| 85 | WNK3 | 0.71143852 |
| 86 | TGFBR1 | 0.68831187 |
| 87 | CAMKK2 | 0.68741555 |
| 88 | CAMK1 | 0.67354949 |
| 89 | CHUK | 0.66501746 |
| 90 | NUAK1 | 0.65318098 |
| 91 | DMPK | 0.65179963 |
| 92 | FER | 0.62743576 |
| 93 | SGK1 | 0.61335304 |
| 94 | DYRK1A | 0.60007393 |
| 95 | CDK11A | 0.59848211 |
| 96 | CDC42BPA | 0.59387189 |
| 97 | PNCK | 0.59156125 |
| 98 | CAMK2A | 0.58952180 |
| 99 | FES | 0.58599262 |
| 100 | DYRK3 | 0.57508380 |
| 101 | TAOK3 | 0.57105923 |
| 102 | CSNK1D | 0.55668111 |
| 103 | MAP3K1 | 0.55606791 |
| 104 | CAMK1D | 0.53186966 |
| 105 | RIPK4 | 0.51644793 |
| 106 | PIK3CA | 0.51511703 |
| 107 | MAP2K1 | 0.51174381 |
| 108 | TIE1 | 0.50307616 |
| 109 | FYN | 0.49767612 |
| 110 | PDK1 | 0.48425370 |
| 111 | CSNK1A1 | 0.47971881 |
| 112 | PDPK1 | 0.47901911 |
| 113 | STK38L | 0.47405481 |
| 114 | CASK | 0.47310581 |
| 115 | DDR2 | 0.46902523 |
| 116 | RPS6KA3 | 0.46257637 |
| 117 | CSNK1A1L | 0.46136366 |
| 118 | PTK2B | 0.45967984 |
| 119 | MAP3K10 | 0.45567994 |
| 120 | NEK1 | 0.44306122 |
| 121 | MKNK1 | 0.43674159 |
| 122 | MAPK10 | 0.41982634 |
| 123 | FRK | 0.41820104 |
| 124 | PRKAA1 | 0.41787630 |
| 125 | ROCK1 | 0.41747352 |
| 126 | OBSCN | 0.41693983 |
| 127 | PRKACA | 0.41420097 |
| 128 | CAMK4 | 0.41403674 |
| 129 | MAPK12 | 0.40871220 |
| 130 | CDK19 | 0.40231149 |
| 131 | FGFR3 | 0.39421139 |
| 132 | MAPK8 | 0.38392438 |
| 133 | ERBB2 | 0.36742681 |
| 134 | PRPF4B | 0.36014109 |
| 135 | CSNK1G3 | 0.35364553 |
| 136 | PRKCI | 0.35273665 |
| 137 | HIPK2 | 0.35231593 |
| 138 | SIK1 | 0.34831129 |
| 139 | PRKG1 | 0.34383359 |
| 140 | DYRK1B | 0.33416053 |
| 141 | RPS6KA6 | 0.33111526 |
| 142 | CSNK1E | 0.32095589 |
| 143 | PRKACB | 0.31351207 |
| 144 | RPS6KA5 | 0.30131848 |
| 145 | GSK3B | 0.27917614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.72497319 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 2.71822614 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.51379447 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.27048343 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26178508 |
| 6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.25832084 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.24162507 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.15400760 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.13162332 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.09805461 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.96406432 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.95479852 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 1.90259386 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.88541204 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.88005520 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.86023152 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.80956553 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.78595874 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76344474 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.72615844 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71965025 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.70618739 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.69545006 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.68297787 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.64107150 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64099830 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.62460053 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.58403627 |
| 29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.57189076 |
| 30 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.56103028 |
| 31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.55376974 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55282805 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.45993651 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45010549 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.41582644 |
| 36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.40743054 |
| 37 | Axon guidance_Homo sapiens_hsa04360 | 1.38688902 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.37048779 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.36750221 |
| 40 | Renin secretion_Homo sapiens_hsa04924 | 1.36546700 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33847111 |
| 42 | Taste transduction_Homo sapiens_hsa04742 | 1.32268409 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.30826803 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.26623398 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 1.25848415 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.21074072 |
| 47 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.18498494 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16861933 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16535515 |
| 50 | Endometrial cancer_Homo sapiens_hsa05213 | 1.15804662 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 1.15616743 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.12865652 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10907076 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.10827901 |
| 55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.09019914 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08682583 |
| 57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07103446 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99925293 |
| 59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.99251982 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99242314 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98862727 |
| 62 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.97754468 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96917234 |
| 64 | Basal transcription factors_Homo sapiens_hsa03022 | 0.94593210 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.93715656 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89951441 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89627963 |
| 68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89440222 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.88967579 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.87158929 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85436789 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85064007 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79868557 |
| 74 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.79825881 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78920859 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.77958295 |
| 77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77841099 |
| 78 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77484867 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75691364 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75670542 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.75512645 |
| 82 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75321515 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74535891 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72783322 |
| 85 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.72771498 |
| 86 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71699515 |
| 87 | Bile secretion_Homo sapiens_hsa04976 | 0.71098306 |
| 88 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70951852 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69528365 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67895683 |
| 91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67111622 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66764451 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66711916 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.65263973 |
| 95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63670612 |
| 96 | Alcoholism_Homo sapiens_hsa05034 | 0.62006182 |
| 97 | Lysine degradation_Homo sapiens_hsa00310 | 0.61622927 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60441774 |
| 99 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60285196 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59592089 |
| 101 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59185948 |
| 102 | Huntingtons disease_Homo sapiens_hsa05016 | 0.59182033 |
| 103 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59163891 |
| 104 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.58542608 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.57629518 |
| 106 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.57457098 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57342331 |
| 108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57204744 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57013551 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57007283 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56887799 |
| 112 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55937663 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.54674452 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54361045 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54285663 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52664759 |
| 117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52361856 |
| 118 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.51995486 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51547336 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51335061 |
| 121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50819027 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49453795 |
| 123 | RNA polymerase_Homo sapiens_hsa03020 | 0.49319912 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49301231 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.49008481 |
| 126 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48420876 |
| 127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47769440 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46869327 |
| 129 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46860884 |
| 130 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46633284 |
| 131 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45945251 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43219533 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43165578 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42362035 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42343817 |
| 136 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.42037388 |
| 137 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40944499 |
| 138 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40820443 |
| 139 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40761026 |
| 140 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40380717 |
| 141 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.39112218 |
| 142 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36012928 |
| 143 | Mineral absorption_Homo sapiens_hsa04978 | 0.34545188 |
| 144 | Protein export_Homo sapiens_hsa03060 | 0.33166476 |

